Is This Experimental Japanese Drug the Secret to Stopping the Flu?
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
A Japanese drug company is offering up a big claim: Shionogi & Co. says it has an experimental pill that can kill the flu virus within a single day, according to news reports.
In a clinical trial, a single dose of the drug made by the pharmaceutical company eliminated the virus from people's bodies in a median time of 24 hours, The Wall Street Journal reported. Both Japanese and American flu patients were included in the trial.
The experimental drug worked three times faster than another antiviral drug, Tamiflu, the company told the Journal.
The drug uses a different approach to fight the flu than other medications. The flu virus spreads through the body by invading cells. Once inside a cell, it hijacks the cell's machinery, forcing the cell to make copies of the virus. Then, the newly copied viruses break out of the cell, spreading to other cells nearby and repeating the process.
Existing drugs, including Tamiflu, work to block these viral copies from escaping the cell, the Journal reported. The experimental drug, however, kicks into action earlier, working to block the virus from hijacking cells in the first place, the Journal said.
Japanese drug regulators could approve the drug for use in Japan by early March, the Journal reported. The drugmaker plans to apply for approval in the U.S. this summer; however, the drug likely wouldn't be available here until next year.
Read more at The Wall Street Journal.
Get the world’s most fascinating discoveries delivered straight to your inbox.
Originally published on Live Science.

